|
[Related PubMed/MEDLINE]
Total Number of Papers: 50
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2023 |
Validation of the motion sickness severity scale: Secondary analysis of a randomized, double-blind, placebo-controlled study of a treatment for motion sickness. |
MSAQ, MSSS |
| 2 |
2022 |
Comparability of a provisioned device versus bring your own device for completion of patient-reported outcome measures by participants with chronic obstructive pulmonary disease: quantitative study findings. |
BYOD, CAT, COPD, E-RS, EXACT, ICCs, PD, PRO, TOSTs |
| 3 |
2022 |
Comparing patient global impression of severity and patient global impression of change to evaluate test-retest reliability of depression, non-small cell lung cancer, and asthma measures. |
ICC, NSCLC, PGIC, PRO |
| 4 |
2022 |
Longitudinal Psychometric Analysis of the Hypertrophic Cardiomyopathy Symptom Questionnaire (HCMSQ) Using Outcomes from the Phase III EXPLORER-HCM Trial. |
EQ VAS, HCM, HCMSQ, HCMSQ, LVOT, NYHA, PGIC, SOB |
| 5 |
2022 |
Memory-Assisted Global Impression of Change (MAGIC). |
MAGIC, PD, PGIC |
| 6 |
2022 |
Minimally Clinically Important Difference in Health Status Scores inPatients With HFrEF vs HFpEF. |
HFpEF, HFrEF, KCCQ, TSS |
| 7 |
2022 |
Qualitative research with patients and caregivers of patients with PIK3CA related overgrowth spectrum: content validity of clinical outcome assessments. |
BPI, CLOVES, CLVM, COAs, FAVA, HRQoL, KT, LM, MCAP or M-CM, PROMIS |
| 8 |
2022 |
Reliability and Validity of an Instrument of COVID-19 Patient-Reported Symptoms in Outpatients. |
SE-C19 |
| 9 |
2021 |
Asthma Daytime Symptom Diary (ADSD) and Asthma Nighttime Symptom Diary (ANSD): Measurement Properties of Novel Patient-Reported Symptom Measures. |
AASDS, ADSD, ANSD |
| 10 |
2021 |
Development and validation of a novel patient-reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine Diary. |
AIM-D, CE, CM, EM, PDAs, PI, PRO |
| 11 |
2021 |
Efficacy and safety of mirabegron in children and adolescents with neurogenic detrusor overactivity: An open-label, phase 3, dose-titration study. |
CGIC, MCC, NDO, PINQ |
| 12 |
2021 |
Pessary or surgery for a symptomatic pelvic organ prolapse: the PEOPLE study, a multicentre prospective cohort study. |
PGI-I, POP |
| 13 |
2021 |
Psychometric evaluation of the Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF) in a phase 2 clinical study. |
GSS, ISM, ISM-SAF, SSS, TSS |
| 14 |
2021 |
Psychometric validation and meaningful within-patient change of the Migraine-Specific Quality of Life questionnaire version 2.1 electronic patient-reported outcome in patients with episodic and chronic migraine. |
CM, EF, EM, ePRO, MSQv2.1, RFP, RFR |
| 15 |
2021 |
Randomized trial comparing efficacy of pelvic floor muscle training with a digital therapeutic motion-based device to standard pelvic floor exercises for treatment of stress urinary incontinence (SUV trial): An all-virtual trial design. |
AE, PFDI-20, PFIQ-7, PFMT, PGI-I, PISQ-IR, SUI |
| 16 |
2021 |
The meaningful change threshold as measured by the 16-item quick inventory of depressive symptomatology in adults with treatment-resistant major depressive and bipolar disorder receiving intravenous ketamine. |
BD, MCT, MDD, QIDS-SR16, TRD |
| 17 |
2021 |
Treatment Satisfaction of Galcanezumab in Japanese Patients with Episodic Migraine: A Phase2 Randomized Controlled Study. |
GMB, PGI-I, PSMQ-M |
| 18 |
2021 |
Urge suppression and modified fluid consumption in the management of female overactive bladder symptoms. |
OAB, PGI-I |
| 19 |
2020 |
Bladder diary characteristics and progress in patients with painful bladder syndrome. |
3dBD, BPIC-SS, BPS, CI, EQ-5D-5L, UF |
| 20 |
2020 |
Efficacy of urodynamic studies in predicting long-term outcomes of the transobturator tape: do they augment clinical assessment? |
ICIQ, ISC, PGI-I, PROMs, SUI, TOT |
| 21 |
2020 |
Galcanezumab for the Management of Migraine: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials. |
CGRP, MHDs, MIDAS, MSQ RF-R, URTI |
| 22 |
2020 |
Mini-Slings: Do They Stand the Test of Time? A 10-Year Cohort. |
PGI-I, SUI |
| 23 |
2020 |
Psychometric evaluation of the DAILY EATS questionnaire in individuals living with obesity. |
EDI, PRO |
| 24 |
2020 |
Single-Incision Mini-Sling for the Treatment of Female Stress Urinary Incontinence: Is it Actually Inferior to Transobturator Vaginal Tape and Tension-Free Vaginal Tape? |
PGI-I, SIMS, SUI, TOT, TVT |
| 25 |
2020 |
Use of the single-item Patient Global Impression-Severity scale as a self-reported assessment of insomnia severity. |
ISI |
| 26 |
2020 |
Validation of a menstrual pictogram and a daily bleeding diary for assessment of uterine fibroid treatment efficacy in clinical studies. |
AH, MP SAP-c v3, UF-DBD |
| 27 |
2019 |
Domain Comparison Between 6 Validated Questionnaires Administered to Women With Urinary Incontinence. |
KHQ, QoL, SUI, UI, UUI |
| 28 |
2019 |
Psychometric Validation of the Role Function Restrictive Domain of the Migraine Specific Quality-of-Life Questionnaire Version 2.1 Electronic Patient-Reported Outcome in Patients With Episodic and Chronic Migraine. |
CM, ePRO, MHD, MIDAS, MSQv2.1, PGI-I, RFR |
| 29 |
2018 |
Efficacy of mace (Arils of Myristica fragrans Houtt) plus PFMT on symptoms in mixed urinary incontinence: a randomized placebo-controlled trial. |
HRQoL, IIQ-7, MUI, PFMT, PGI-I, UDI-6 |
| 30 |
2018 |
Independent validation of the Quality of Life in Essential Tremor Questionnaire (QUEST). |
QUEST |
| 31 |
2017 |
Adult Onset Nocturnal Enuresis: Identifying Causes, Cofactors and Impact on Quality of Life. |
AUAss, HRQL, NE, NGB, OAB-q SF, OSA |
| 32 |
2017 |
Clinical, psychological features and quality of life of fibromyalgia patients: a cross-sectional study of Chinese sample. |
ACR, FM, PGI-B, PLA |
| 33 |
2017 |
Evaluation and performance of a newly developed patient-reported outcome instrument for diarrhea-predominant irritable bowel syndrome in a clinical study population. |
IBS-D, PGIC, SD |
| 34 |
2016 |
[Assessment of severity of neurogenic bowel dysfunction in chronic patients with a simple 1-item questionnaire (PGI-S)]. |
NBD |
| 35 |
2015 |
Preliminary experience using milnacipran in patients with juvenile fibromyalgia: lessons from a clinical trial program. |
AEs, FM, JFM, LTR, MASC |
| 36 |
2014 |
Mini-arc for the treatment of female stress urinary incontinence: long-term prospective evaluation by patient reported outcomes. |
PGI-I, SUI |
| 37 |
2014 |
Observational Study of IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm (XCiDaBLE): Interim Results for the First 170 Subjects with Blepharospasm. |
CGI-S, IVRS/IWRS, JRS, QoL |
| 38 |
2014 |
Validation of a bladder symptom screening tool in women with incontinence due to overactive bladder. |
ABSST, MS, OAB, OAB-q SF, UUI |
| 39 |
2014 |
[Efficacy of periurethral injections of polyacrylamide hydrogel (Bulkamid()) and quality of life of patients with urinary incontinence due to sphincter deficiency (IUE-IS)]. |
ICIQ-SF, IUE-IS, PGI-I, SUI |
| 40 |
2013 |
Intra-vaginal diazepam for high-tone pelvic floor dysfunction: a randomized placebo-controlled trial. |
EMG, FSFI, PGI-I, VAS |
| 41 |
2013 |
Single incision mid-urethral slings: impact of obesity on outcomes. |
BMI, PGI-I, SIS, W-IPSS |
| 42 |
2012 |
Construct validation of patient global impression of severity (PGI-S) and improvement (PGI-I) questionnaires in the treatment of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. |
ANOVA, BII, BPH, IPSS, IPSS-QoL, LUTS |
| 43 |
2011 |
Rescue leads: a salvage technique for selected patients with a suboptimal response to standard DBS therapy. |
DBS, TRS, UDRS, Vo |
| 44 |
2011 |
[Success of treatment in higher stages of pain chronification as well? An evaluation of the Mainz pain staging system based on the QUAST-analysis sample]. |
MPSS |
| 45 |
2010 |
Relationship between higher rates of adverse events in deep brain stimulation using standardized prospective recording and patient outcomes. |
AE, DBS, PD, QoL |
| 46 |
2009 |
Patient-rated troubling symptoms of depression instrument results correlate with traditional clinician- and patient-rated measures: a secondary analysis of a randomized, double-blind, placebo-controlled trial. |
CGI-S, PaRTS-D, Q-LES-Q, SDS |
| 47 |
2008 |
TVT-secur: a minimally invasive procedure for the treatment of primary stress urinary incontinence. One year data from a multi-centre prospective trial. |
PGI-I, QoL, W-IPSS |
| 48 |
2007 |
Peri-operative morbidity and early results of a randomised trial comparing TVT and TVT-O. |
W-IPSS |
| 49 |
2007 |
Transfascial vaginal tape (TFT): a simple, safe and cost-effective procedure for stress urinary incontinence. A preliminary study. |
I-QOL, TFT |
| 50 |
2003 |
Mixed urinary incontinence symptoms: urodynamic findings, incontinence severity, and treatment response. |
I-QOL |
|
A Search Service for Abbreviation / Long Form
